Collagen fiber synthesis

Collagen fiber synthesis does **not** refer to a discrete molecular target but rather to a complex *multi-step biosynthetic process* encompassing transcription, translation, post-translational modification, secretion, and assembly of collagen molecules into fibrils and fibers[1][3][5][7]. Most notably studied is the synthesis of type I collagen, which involves the synthesis of procollagen in fibroblasts, post-translational modifications (hydroxylation of proline and lysine residues—vitamin C dependent—plus glycosylation), formation of a triple helix, secretion, cleavage of propeptides, and extracellular assembly into mature fibers[1][3][5]. Defects in this process underlie several connective tissue diseases and fibrotic disorders, and multiple enzymes and chaperones are involved in its regulation. However, "collagen fiber synthesis" is not a molecular entity or canonical drug target, but a broad biological pathway/process[1][5][7]. **Key facts supporting this classification:** - "Collagen fiber synthesis" encompasses many enzymes (e.g., prolyl hydroxylase, lysyl hydroxylase, lysyl oxidase), chaperones, and regulatory factors, each of which could be targeted, but the term itself designates the *biosynthetic process*, not a specific protein or receptor[1][5][7]. - There is no canonical abbreviation or standard gene/protein symbol for "collagen fiber synthesis". - The process is central to the formation and remodeling of the extracellular matrix in connective tissues, and its dysregulation is implicated in fibrosis, genetic collagenopathies (e.g., Ehlers-Danlos syndrome, osteogenesis imperfecta), scurvy, and various autoimmune conditions[6][7]. - Many drugs indirectly affect this process (such as anti-fibrotics or agents affecting vitamin C status), but no small molecule directly targets "collagen fiber synthesis" as a singular entity. **Summary judgment:** "Collagen fiber synthesis" is **not a molecular target**, is not a receptor, enzyme, or gene, and should not be treated as a canonical drug target. It is best described as a multi-component pathway, and further disambiguation (e.g., specifying individual enzymes or regulatory factors) is required for structured drug target information[1][3][5].

Other names

Collagen biosynthesisCollagen fibril synthesisCollagen production